SUDOSCAN
THERAPEUTIC AREAS
Diabetes
SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.

Neurology
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.

Oncology
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).

Nephrology
SUDOSCAN has demonstrated its clinical utility in Nephrology.

Follow-up
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.

Diabetes Risk
Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score
SCIENCE & RESEARCH
WHO WE ARE
- About Impeto Medical
- Impeto Medical in the World

Scientific news

Scientific news

Scientific newsSebastien2026-05-28T14:23:22+00:00

DiabetesScientific publications
Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes
Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes
June 18, 2021

Neurological diseases / Scientific publications

SUDOSCAN combined to other diagnosis tests to confirm small fiber neuropathy
Read Article
Cardiac neuropathy / Diabetes / Scientific publications

The utility of SUDOSCAN to diagnose diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy
THE UTILITY OF SUDOSCAN TO DIAGNOSE DIABETIC CARDIOVASCULAR AUTONOMIC NEUROPATHY [...]

Read Article
Diabetes / Scientific publications

The benefits of SUDOSCAN in early diagnosis of diabetic peripheral neuropathy reviewed in The Lancet
THE BENEFITS OF SUDOSCAN IN EARLY DIAGNOSIS OF DIABETIC PERIPHERAL [...]

Read Article
Follow-up with SUDOSCAN / Scientific publications

Longitudinal follow-up with SUDOSCAN
LONGITUDINAL FOLLOW-UP: SUDOSCAN DEMONSTRATED EFFICACY IN RESULTS FOLLOW-UP SUDOSCAN has [...]

Read Article

Subscribe to receive our scientific news

Email(Required)

Name(Required)

Events
Meet Sudoscan at the 61th EASD Annual Congress 2025
October 31, 2026
Events
Meet Sudoscan at the 35th NEUROdiab Annual Congress 2025
October 31, 2026
Events
Meet Sudoscan at the 11th EAN Congress 2025
October 31, 2026

About Sudoscan

Sudoscan is a class IIa Medical device, Manufactured by Impeto Medical, indicated for early identification and follow-up of peripheral autonomic neuropathies.

For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark

Sudoscan in the world

More information

Sudoscan Technology

Contact info

France HEADQUARTERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux
Phone: +33 (0)7 87 20 32 03

Sudoscan USA: 8525 Gibbs Dr Suite 304, San Diego, CA 92123, États-Unis
Phone: 858-450-2800

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12

Innovations in Autonomic Function Testing

Contact Info

France HEADQUATERS: 2 rue Maurice Hartmann, 92130 Issy Les Moulineaux

Phone: +33 (0)7 87 20 32 03

sudoscan-homepage-photo-2023-6

Discover SudoscanDiscover Sudoscan